atovaquone 250 mg proguanil 100 mg

1 INDICATIONS AND USAGE Atovaquone and proguanil hydrochloride tablets are an antimalarial indicated for: • prophylaxis of Plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. ( 1.1 ) • treatment of acute, uncomplicated P. falciparum malaria. ( 1.2 ) 1.1 Prevention of Malaria Atovaquone and proguanil hydrochloride tablets are indicated for the prophylaxis of Plasmodium falciparum malaria, including in areas where chloroquine resistance has been reported. 1.2 Treatment of Malaria Atovaquone and proguanil hydrochloride tablets are indicated for the treatment of acute, uncomplicated P. falciparum malaria. Atovaquone and proguanil hydrochloride tablets have been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance.

A-S Medication Solutions

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] pain` `[3] fatigue` `[4] rash` `[5] rheumatoid arthritis` `[6] abdominal discomfort` `[7] alopecia` `[8] off label use` `[9] systemic lupus erythematosus` `[10] glossodynia`

5 months ago

ROUND PINK G 404

16 HOW SUPPLIED/STORAGE AND HANDLING Product: 50090-1302 NDC: 50090-1302-0 7 TABLET, film coated in a BOTTLE NDC: 50090-1302-1 12 TABLET, film coated in a BOTTLE NDC: 50090-1302-2 14 TABLET, film coated in a BOTTLE NDC: 50090-1302-3 16 TABLET, film coated in a BOTTLE NDC: 50090-1302-4 24 TABLET, film coated in a BOTTLE NDC: 50090-1302-5 5 TABLET, film coated in a BOTTLE NDC: 50090-1302-6 10 TABLET, film coated in a BOTTLE NDC: 50090-1302-7 100 TABLET, film coated in a BOTTLE NDC: 50090-1302-8 20 TABLET, film coated in a BOTTLE NDC: 50090-1302-9 30 TABLET, film coated in a BOTTLE

More pills like ROUND G 404

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

atovaquone 250 mg proguanil 100 mg

FDA Reported Adverse Reactions [1] drug ineffective [2] pain [3] fatigue [4] rash [5] rheumatoid arthritis [6] abdominal discomfort [7] alopecia [8] off label use [9] systemic lupus erythematosus [10] glossodynia

ROUND PINK G 404

More pills like ROUND G 404

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] pain` `[3] fatigue` `[4] rash` `[5] rheumatoid arthritis` `[6] abdominal discomfort` `[7] alopecia` `[8] off label use` `[9] systemic lupus erythematosus` `[10] glossodynia`